Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 3
1950 3
1951 7
1952 1
1953 4
1954 9
1955 4
1956 8
1957 4
1958 4
1959 6
1960 5
1961 5
1962 6
1963 24
1964 32
1965 35
1966 20
1967 25
1968 30
1969 46
1970 51
1971 56
1972 63
1973 62
1974 74
1975 71
1976 62
1977 74
1978 117
1979 75
1980 77
1981 76
1982 93
1983 101
1984 117
1985 111
1986 111
1987 121
1988 147
1989 164
1990 166
1991 171
1992 155
1993 161
1994 170
1995 170
1996 197
1997 214
1998 224
1999 239
2000 284
2001 290
2002 339
2003 318
2004 360
2005 377
2006 431
2007 418
2008 435
2009 470
2010 569
2011 629
2012 733
2013 768
2014 844
2015 941
2016 909
2017 970
2018 987
2019 1117
2020 1280
2021 1347
2022 1338
2023 1272
2024 1341
2025 1504
2026 563

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,570 results

Results by year

Filters applied: . Clear all
Page 1
Nasopharyngeal carcinoma.
Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Chen YP, et al. Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178151 Review.
Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is particularly prevalent in east and southeast Asia. ...Among the existing developments in novel therapeutics, immune checkpoint therapies have achieved breakthroughs for treating r …
Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is particularly prevalent in east and sout …
Epidemiology of nasopharyngeal carcinoma: current insights and future outlook.
Su ZY, Siak PY, Lwin YY, Cheah SC. Su ZY, et al. Cancer Metastasis Rev. 2024 Sep;43(3):919-939. doi: 10.1007/s10555-024-10176-9. Epub 2024 Mar 2. Cancer Metastasis Rev. 2024. PMID: 38430391 Review.
Nasopharyngeal carcinoma (NPC) is characterised by its remarkable geographical and ethnic distribution. ...
Nasopharyngeal carcinoma (NPC) is characterised by its remarkable geographical and ethnic distribution. ...
Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers.
Liang C, Kan J, Wang J, Lu W, Mo X, Zhang B. Liang C, et al. Front Immunol. 2024 Oct 17;15:1448012. doi: 10.3389/fimmu.2024.1448012. eCollection 2024. Front Immunol. 2024. PMID: 39483474 Free PMC article. Review.
Nasopharyngeal carcinoma (NPC) is a neoplasm related to inflammation; the expression of cytokines, such as CCL3, CCL4, CCL20, IL-1alpha, IL-1beta, IL-6, IL-8, and IL-10, among others, is presumed to be associated with NPC occurrence and development. ...
Nasopharyngeal carcinoma (NPC) is a neoplasm related to inflammation; the expression of cytokines, such as CCL3, CCL4, CCL20, …
Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma.
Jiang W, Lv JW, Tang LL, Sun Y, Chen YP, Ma J. Jiang W, et al. Cell Rep Med. 2024 Jun 18;5(6):101594. doi: 10.1016/j.xcrm.2024.101594. Epub 2024 Jun 5. Cell Rep Med. 2024. PMID: 38843843 Free PMC article. Review.
When applied as the standard therapeutic modality, intensity-modulated radiotherapy (IMRT) improves local control and survival rates in patients with nasopharyngeal carcinoma (NPC). However, distant metastasis continues to be the leading cause of treatment failure. …
When applied as the standard therapeutic modality, intensity-modulated radiotherapy (IMRT) improves local control and survival rates in pati …
MR Imaging of Nasopharyngeal Carcinoma.
King AD. King AD. Magn Reson Imaging Clin N Am. 2022 Feb;30(1):19-33. doi: 10.1016/j.mric.2021.06.015. Magn Reson Imaging Clin N Am. 2022. PMID: 34802578 Free article. Review.
Nasopharyngeal carcinoma is endemic in parts of the world such as southern China and Southeast Asia. It is predominantly an undifferentiated carcinoma with a strong genetic basis and a close association with the Epstein-Barr virus. ...
Nasopharyngeal carcinoma is endemic in parts of the world such as southern China and Southeast Asia. It is predominantly an un …
Nasopharyngeal carcinoma and microbiome: Evidence and implications.
Su ZY, Chen WC, Siak PY, Guo X, Cheah SC. Su ZY, et al. Crit Rev Oncol Hematol. 2025 Dec;216:104986. doi: 10.1016/j.critrevonc.2025.104986. Epub 2025 Oct 24. Crit Rev Oncol Hematol. 2025. PMID: 41284501 Review.
Nasopharyngeal carcinoma (NPC) is raising concern in its endemic regions due to its high propensity for metastasis and frequent late-stage diagnosis. ...Given these associations, non-invasive, radiation-free screening tools utilising oral and nasopharyngeal b …
Nasopharyngeal carcinoma (NPC) is raising concern in its endemic regions due to its high propensity for metastasis and frequen …
Deciphering nasopharyngeal carcinoma pathogenesis via proteomics.
Xiao Z, Chen Z. Xiao Z, et al. Expert Rev Proteomics. 2019 Jun;16(6):475-485. doi: 10.1080/14789450.2019.1615891. Epub 2019 May 16. Expert Rev Proteomics. 2019. PMID: 31056975 Review.
Introduction: Nasopharyngeal carcinoma (NPC) is a distinct head and neck squamous cell carcinoma in its etiological association of Epstein-Barr virus (EBV) infection, hidden anatomical location, remarkable racial and geographical distribution, and high incide …
Introduction: Nasopharyngeal carcinoma (NPC) is a distinct head and neck squamous cell carcinoma in its etiological ass …
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.
Huang SY, Gong S, Zhao Y, Ye ML, Li JY, He QM, Qiao H, Tan XR, Wang JY, Liang YL, Huang SW, He SW, Li YQ, Xu S, Li YQ, Liu N. Huang SY, et al. Nat Commun. 2024 Jun 21;15(1):5300. doi: 10.1038/s41467-024-49675-2. Nat Commun. 2024. PMID: 38906860 Free PMC article.
Chemoresistance is a main reason for treatment failure in patients with nasopharyngeal carcinoma, but the exact regulatory mechanism underlying chemoresistance in nasopharyngeal carcinoma remains to be elucidated. Here, we identify PJA1 as a key E3 ubi …
Chemoresistance is a main reason for treatment failure in patients with nasopharyngeal carcinoma, but the exact regulatory mec …
Anti-EGFR therapies in nasopharyngeal carcinoma.
Chen X, Liang R, Zhu X. Chen X, et al. Biomed Pharmacother. 2020 Nov;131:110649. doi: 10.1016/j.biopha.2020.110649. Epub 2020 Aug 21. Biomed Pharmacother. 2020. PMID: 32836074 Free article. Review.
Nasopharyngeal carcinoma (NPC) is a common malignant tumor in Southern China and South-East Asia. ...
Nasopharyngeal carcinoma (NPC) is a common malignant tumor in Southern China and South-East Asia. ...
22,570 results
You have reached the last available page of results. Please see the User Guide for more information.